跳至主要内容
临床试验/IRCT20201201049553N1
IRCT20201201049553N1尚未招募3 期

Evaluating the effect of Pregabalin in treatment of Behavioral and psychological symptoms of dementia(BPSD)

Tehran University of Medical Sciences Deputy of Research and Technology0 个研究点目标入组 58 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with dementia of the following types: Alzheimer's, vascular dementia or mixed vascular dementia, based on DSM V criteria
  • Patients with moderate to severe dementia based on the result of diagnostic tools such as FAST or MoCA

排除标准

  • Other types of dementia such as Lewy body or frontotemporal dementia
  • History of major psychological disorders
  • History of drug abuse
  • History of epilepsy or other neurological disorders such as Multiple Sclerosis or head concussion which may exacerbate behavioral symptoms

研究者

发起方
Tehran University of Medical Sciences Deputy of Research and Technology

相似试验

Effect of Pregabalin in Behavioral and psychological... | 临床试验